文献速递技术与安全神经腹部MR

单剂量钆基对比剂后大型动物模型中的钆组织分布

Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents.
PubMed 文献 · Radiology · 2021-09-21

该前瞻性动物研究比较了单次注射线性与大环状钆基对比剂10周后羊各器官的钆浓度,发现线性对比剂在肾脏和肝脏浓度最高,大环状对比剂组织浓度低且与对照组无显著差异,所有器官均未见组织学损伤。

要点

  • 线性对比剂组织钆浓度为大环状的3至21倍,肾脏和肝脏是主要蓄积器官。
  • 大环状对比剂在肾脏、肝脏和深部小脑核团的浓度与对照组无显著差异。
  • 尽管存在钆蓄积,所有检查器官均未观察到组织病理学改变。

诊断标准与关键数值

  • 线性对比剂组肾脏平均钆浓度502 ng/g(95% CI: 270, 734),肝脏445 ng/g(95% CI: 202, 687),深部小脑核团30 ng/g(95% CI: 20, 41)。
  • 大环状对比剂组肾脏平均钆浓度86 ng/g(95% CI: 31, 141,P = .08),肝脏21 ng/g(95% CI: 4, 39,P = .15),深部小脑核团10 ng/g(95% CI: 9, 12,P > .99),与对照组相比均无显著升高。
  • 线性对比剂组织浓度为大环状对比剂的3至21倍。

临床应用与阅片要点

  • 阅片时注意:使用线性对比剂后肾脏和肝脏钆蓄积浓度较高,但本研究未发现组织学损伤,报告时不应将钆蓄积等同于组织损伤。
  • 选择对比剂时可参考:大环状对比剂组织钆浓度低且与对照组无显著差异,但需结合临床指南综合判断。

局限性

  • 动物模型(羊)结果外推至人类需谨慎。
  • 仅评估单次注射后10周一个时间点,未观察更长期蓄积。
  • 样本量有限(36只),且未报告随机化盲法细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background There is an ongoing scientific debate about the degree and clinical importance of gadolinium deposition in the brain and other organs after administration of gadolinium-based contrast agents (GBCAs). While most published data focus on gadolinium deposition in the brain, other organs are rarely investigated. Purpose To compare gadolinium tissue concentrations in various organs 10 weeks after one injection (comparable to a clinically applied dose) of linear and macrocyclic GBCAs in a large-animal model. Materials and Methods In this prospective animal study conducted from March to May 2018, 36 female Swiss-Alpine sheep (age range, 4-10 years) received one injection (0.1 mmol/kg) of macrocyclic GBCAs (gadobutrol, gadoteridol, and gadoterate meglumine), linear GBCAs (gadodiamide and gadobenate dimeglumine), or saline. Ten weeks after injection, sheep were sacrificed and tissues were harvested. Gadolinium concentrations were quantified with inductively coupled plasma mass spectrometry (ICP-MS). Histologic staining was performed. Data were analyzed with nonparametric tests. Results At 10 weeks after injection, linear GBCAs resulted in highest mean gadolinium concentrations in the kidney (502 ng/g [95% CI: 270, 734]) and liver (445 ng/g [95% CI: 202, 687]), while low concentrations were found in the deep cerebellar nuclei (DCN) (30 ng/g [95% CI: 20, 41]). Tissue concentrations of linear GBCAs were three to 21 times higher compared with those of macrocyclic GBCAs. Administered macrocyclic GBCAs resulted in mean gadolinium concentrations of 86 ng/g (95% CI: 31, 141) (P = .08) in the kidney, 21 ng/g (95% CI: 4, 39) (P = .15) in liver tissue, and 10 ng/g (95% CI: 9, 12) (P > .99) in the DCN, which were not significantly elevated when compared with concentrations in control animals. No histopathologic alterations were observed irrespective of tissue concentrations within any examined organ. Conclusion Ten weeks after one injection of a clinically relevant dose of gadolinium-based contrast agents, the liver and kidney appeared to be reservoirs of gadolinium; however, despite gadolinium presence, no tissue injury was detected. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Clément in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Richter H, Bücker P, Martin LF, et al. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents. Radiology. 2021. PMID: 34546128. doi:10.1148/radiol.2021210553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。